Jackson Creek Investment Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,589
Closed -$1.48M 350
2025
Q1
$1.48M Sell
17,589
-12
-0.1% -$1.12K 0.47% 76
2024
Q4
$1.62M Sell
17,601
-549
-3% -$52.8K 0.49% 65
2024
Q3
$1.69M Buy
18,150
+4,072
+29% +$353K 0.5% 56
2024
Q2
$1.16M Buy
+14,078
New +$1.03M 0.42% 73
2021
Q4
Sell
-22,003
Closed -$1.17M 329
2021
Q3
$1.17M Buy
22,003
+203
+0.9% +$11.4K 0.43% 68
2021
Q2
$1.33M Buy
+21,800
New +$1.16M 0.49% 27

Other funds holding LMAT

Jackson Creek Investment Advisors's LMAT Position: Q2 2025 in Review

Jackson Creek Investment Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 17,589 shares — an estimated $1.48M sold.

Jackson Creek Investment Advisors first reported a position in LMAT in Q2 2021 and held it in 6 quarters. The position peaked at $1.69M in Q3 2024. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

  • Jackson Creek Investment Advisors reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 17,589 LeMaitre Vascular shares in Q2 2025, an estimated $1.48M.
  • Jackson Creek Investment Advisors first reported a position in LeMaitre Vascular in Q2 2021 and held it in 6 quarters.
  • Jackson Creek Investment Advisors's LeMaitre Vascular position peaked at $1.69M in Q3 2024.
  • 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.